Description of a video on a 6-month micronutrient trial for eye floaters
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description says the video breaks down the 2021 FLIES trial, a 6-month double-blind study of a 5-ingredient micronutrient formulation in people with vitreous floaters, covering subjective discomfort, objective shadow imaging and contrast sensitivity, plus the study's commercial funding ties. [1]
The description says the video breaks down the 2021 FLIES trial, a 6-month double-blind clinical trial of a 5-ingredient micronutrient formulation (L-lysine, citrus bioflavonoids, grape seed extract, vitamin C, zinc). [1]
The description lists three presented findings: subjective floater discomfort and symptoms, objective floater shadow area reduction, and contrast sensitivity and visual acuity. [1]
The description says the video analyses the study's commercial funding ties and highlights red flags of retinal tears requiring immediate emergency care. [1]
FLIES trial: 6-month micronutrient study in floaters
According to the description, the video examines the 2021 FLIES trial (Floater Intervention Study), published in Translational Vision Science & Technology. It is described as a 6-month double-blind clinical trial of a 5-ingredient formulation: L-lysine, citrus bioflavonoids, grape seed extract, vitamin C and zinc. The description says the human data covered subjective discomfort, objective 2D infrared shadow imaging and functional contrast sensitivity. It also says the video addresses viral pineapple and bromelain myths and outlines daily habits for vitreous health. [1]
Described findings on discomfort, shadows and contrast
The description lists three findings the video presents: subjective floater discomfort and symptoms, objective floater shadow area reduction, and contrast sensitivity and visual acuity. It does not report effect sizes, direction of every result or statistical details in the description itself. The description frames the question as whether targeted oral micronutrients can reduce floaters or whether surgery is the only option, and notes that surgical vitrectomy and Nd:YAG laser vitreolysis carry invasive risks that make them unsuitable for mild to moderate age-related floaters. [1]
Funding ties and red-flag warnings in the description
The description says the video analyses the study's commercial funding ties and study limitations, and highlights red flags of retinal tears that require immediate emergency care. It also states that floaters can occasionally be the presenting symptom of serious eye conditions, including retinal tears or retinal detachment, and advises consulting an ophthalmologist or optometrist before starting a supplement or with sudden vision changes. The description presents the video as educational and not medical advice. [1]
Context & limits
Only the video description was reviewed; the video and transcript were not reviewed. All details come from the description and its creator, including the trial findings, which are not independently verified here. The description gives no effect sizes or full results.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
6-month double-blind FLIES clinical trial
Finding 2: Objective Floater Shadow Area Reduction
Industry Funding & Study Limitations
About this video
Creator description · original textText language: English
Modern Healthspan · 16 min · Source published: 2026-09-28
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.